Share:
Peer-Reviewed Publication
JACC Heart Fail2026;14(1):102750.January 1, 2026Letter

REPLY: Real-World Challenges for Noninvasive Hemodynamic Monitoring in Heart Failure.

Andrew M Carek1, Omer T Inan2, Andrew P Ambrosy3, Liviu Klein4
1Cardiosense, Chicago, Illinois, USA.
2Cardiosense, Chicago, Illinois, USA; Georgia Institute of Technology, Atlanta, Georgia, USA. Electronic address: oeinan@gmail.com.
3Kaiser Permanente, San Francisco, California, USA; Kaiser Permanente Northern California, Pleasanton, California, USA.
4University of California-San Franciso, San Francisco, California, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.